Index RUT
P/E -
EPS (ttm) -3.37
Insider Own 22.64%
Shs Outstand 49.75M
Perf Week 1.71%
Market Cap 1.40B
Forward P/E -
EPS next Y -4.26
Insider Trans -0.27%
Shs Float 38.71M
Perf Month -14.64%
Income -152.09M
PEG -
EPS next Q -0.97
Inst Own 84.39%
Short Float 16.15%
Perf Quarter -4.57%
Sales 0.52M
P/S 2692.54
EPS this Y -8.99%
Inst Trans -1.45%
Short Ratio 12.63
Perf Half Y 36.55%
Book/sh 14.01
P/B 2.00
EPS next Y -8.89%
ROA -27.88%
Short Interest 6.25M
Perf Year -40.09%
Cash/sh 14.08
P/C 1.99
EPS next 5Y -
ROE -29.08%
52W Range 19.34 - 63.08
Perf YTD -3.12%
Dividend Est. -
P/FCF -
EPS past 5Y -35.64%
ROI -21.80%
52W High -55.65%
Beta 1.47
Dividend TTM -
Quick Ratio 28.94
Sales past 5Y 134.56%
Gross Margin -109.40%
52W Low 44.64%
ATR (14) 1.48
Dividend Ex-Date -
Current Ratio 28.94
EPS Y/Y TTM -116.41%
Oper. Margin -34296.74%
RSI (14) 37.32
Volatility 4.86% 4.80%
Employees 121
Debt/Eq 0.00
Sales Y/Y TTM -99.26%
Profit Margin -29192.90%
Recom 1.40
Target Price 56.00
Option/Short Yes / Yes
LT Debt/Eq 0.00
EPS Q/Q -29.60%
Payout -
Rel Volume 1.56
Prev Close 27.69
Sales Surprise -
EPS Surprise 3.70%
Sales Q/Q -100.00%
Earnings Apr 25 BMO
Avg Volume 495.13K
Price 27.98
SMA20 -7.02%
SMA50 -16.69%
SMA200 -21.12%
Trades
Volume 772,240
Change 1.05%
Date
Action
Analyst
Rating Change
Price Target Change
Dec-08-23 Initiated
Citigroup
Buy
$46
Sep-25-23 Reiterated
Stifel
Hold
$61 → $33
Sep-25-23 Downgrade
BTIG Research
Buy → Neutral
Aug-09-23 Downgrade
Stifel
Buy → Hold
$69 → $61
Sep-07-22 Initiated
Stifel
Buy
$44
Jul-20-22 Initiated
SVB Leerink
Outperform
$45
Mar-31-22 Initiated
Canaccord Genuity
Buy
$68
Feb-11-22 Initiated
BTIG Research
Buy
$64
Dec-08-21 Initiated
Wells Fargo
Overweight
$81
Oct-26-20 Initiated
RBC Capital Mkts
Outperform
$35
Jul-22-19 Initiated
Wells Fargo
Outperform
Jul-22-19 Initiated
Jefferies
Buy
Jul-22-19 Initiated
Cowen
Outperform
Jul-22-19 Initiated
BMO Capital Markets
Outperform
$30
Show Previous Ratings
Today 01:53PM
08:37AM
07:00AM
Apr-24-24 12:00PM
Mar-20-24 01:57PM
08:00AM
Loading…
Mar-19-24 08:00AM
Mar-05-24 04:05PM
Feb-26-24 09:55AM
Feb-22-24 07:00AM
Feb-08-24 09:55AM
Jan-18-24 01:04AM
Jan-05-24 09:55AM
Jan-03-24 04:05PM
Dec-20-23 09:55AM
Dec-01-23 03:59PM
09:55AM
Loading…
09:55AM
Nov-15-23 09:55AM
Nov-10-23 08:00AM
Nov-09-23 12:00PM
Nov-06-23 04:24PM
Nov-03-23 08:46AM
07:00AM
Oct-09-23 08:00AM
Sep-28-23 06:27AM
(American City Business Journals)
Sep-26-23 04:10PM
Sep-25-23 04:08PM
(Investor's Business Daily) -36.91%
12:58PM
(American City Business Journals)
Sep-22-23 05:30PM
Sep-09-23 01:01PM
Aug-29-23 08:00AM
04:05PM
Loading…
Aug-09-23 04:05PM
Aug-07-23 06:24AM
Aug-03-23 08:55AM
07:05AM
Jun-08-23 03:22PM
Jun-06-23 04:05PM
May-26-23 03:31PM
May-22-23 05:23PM
May-12-23 08:30AM
May-11-23 08:00AM
May-07-23 07:40PM
May-06-23 08:13AM
May-05-23 10:30AM
09:23AM
(Thomson Reuters StreetEvents)
May-03-23 12:13AM
May-02-23 04:02PM
Apr-30-23 08:10AM
Apr-29-23 08:25AM
Apr-27-23 06:10AM
Apr-26-23 07:06AM
Apr-25-23 11:54AM
08:15AM
07:00AM
06:59AM
Apr-24-23 04:01PM
Apr-18-23 10:56AM
04:20AM
Apr-09-23 01:19PM
Mar-18-23 08:29AM
Mar-03-23 09:05AM
Feb-24-23 05:26AM
Feb-23-23 08:00AM
Feb-15-23 09:04AM
Feb-14-23 08:00AM
Jan-26-23 05:54AM
(American City Business Journals)
Jan-13-23 07:26AM
Jan-05-23 09:09AM
Dec-15-22 06:48AM
Nov-22-22 08:00AM
Nov-09-22 08:00AM
Nov-04-22 06:29AM
Nov-02-22 09:15AM
08:00AM
Oct-28-22 12:07PM
Oct-27-22 12:26PM
Oct-25-22 04:05PM
01:59PM
Oct-24-22 08:00AM
Oct-20-22 01:19PM
Oct-10-22 08:00AM
Sep-30-22 01:20PM
10:22AM
Sep-29-22 12:00PM
10:15AM
Sep-28-22 12:00PM
Sep-27-22 12:46PM
Sep-26-22 12:39PM
11:17AM
Sep-23-22 11:14AM
11:02AM
Sep-22-22 01:28PM
Sep-21-22 11:44AM
07:00AM
Sep-20-22 12:10PM
Sep-19-22 12:28PM
12:21PM
Sep-16-22 11:42AM
Sep-15-22 12:15PM
11:54AM
Sep-14-22 01:33PM
Morphic Holding, Inc., operates as a biopharmaceutical company, which researches and develops oral small-molecule integrin therapeutics. It operates a Morphic integrin technology platform, MInT platform, to create a broad pipeline of programs across a variety of therapeutic areas. The company was founded by Timothy A. Springer in August 2014 and is headquartered in Waltham, MA.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Rogers Bruce PRESIDENT Mar 27 '24 Option Exercise 4.32 7,400 31,932 149,883 Mar 28 07:00 PM Tipirneni Praveen P. CEO Jan 16 '24 Sale 27.49 13,923 382,753 42,013 Jan 17 07:04 PM Rogers Bruce President Jan 16 '24 Sale 27.49 6,314 173,576 142,036 Jan 17 07:02 PM SCHEGERIN MARC CFO and COO Jan 16 '24 Sale 27.49 6,041 166,071 37,460 Jan 17 07:03 PM Farrell Robert E Jr SVP Finance and CAO Jan 16 '24 Sale 27.49 5,089 139,900 34,992 Jan 17 07:01 PM DeVaul William General Counsel and Secretary Jan 16 '24 Sale 27.49 4,509 123,956 23,029 Jan 17 07:00 PM Farrell Robert E Jr SVP Finance and CAO Jan 14 '24 Option Exercise 0.00 3,470 0 40,081 Jan 17 07:01 PM DeVaul William General Counsel and Secretary Jan 14 '24 Option Exercise 0.00 3,250 0 27,538 Jan 17 07:00 PM Rogers Bruce President Jan 14 '24 Option Exercise 0.00 5,070 0 148,350 Jan 17 07:02 PM SCHEGERIN MARC CFO and COO Jan 14 '24 Option Exercise 0.00 4,690 0 43,501 Jan 17 07:03 PM Tipirneni Praveen P. CEO Jan 14 '24 Option Exercise 0.00 12,500 0 55,936 Jan 17 07:04 PM Tipirneni Praveen P. CEO Jan 13 '24 Option Exercise 0.00 29,500 0 43,436 Jan 17 07:04 PM SCHEGERIN MARC CFO and COO Jan 13 '24 Option Exercise 0.00 14,675 0 38,811 Jan 17 07:03 PM Rogers Bruce President Jan 13 '24 Option Exercise 0.00 15,225 0 143,280 Jan 17 07:02 PM DeVaul William General Counsel and Secretary Jan 13 '24 Option Exercise 0.00 10,950 0 24,288 Jan 17 07:00 PM Farrell Robert E Jr SVP Finance and CAO Jan 13 '24 Option Exercise 0.00 12,675 0 36,611 Jan 17 07:01 PM SLATTERY JOSEPH P Director Nov 13 '23 Buy 20.60 2,400 49,436 9,066 Nov 14 07:04 PM Edwards Martin Director Nov 13 '23 Buy 20.54 2,376 48,803 2,376 Nov 15 07:00 PM SCHEGERIN MARC CFO and COO Sep 07 '23 Option Exercise 15.00 20,000 300,000 44,136 Sep 08 07:00 PM SCHEGERIN MARC CFO and COO Sep 07 '23 Sale 54.34 20,000 1,086,849 24,136 Sep 08 07:00 PM Tipirneni Praveen P. President and CEO Aug 01 '23 Option Exercise 4.32 3,597 15,539 17,533 Aug 03 06:58 PM Tipirneni Praveen P. President and CEO Aug 01 '23 Sale 57.04 3,597 205,187 13,936 Aug 03 06:58 PM Tipirneni Praveen P. President and CEO Jul 03 '23 Option Exercise 4.32 3,597 15,539 17,533 Jul 06 07:02 PM Tipirneni Praveen P. President and CEO Jul 03 '23 Sale 57.04 3,597 205,178 13,936 Jul 06 07:02 PM Tipirneni Praveen P. President and CEO Jun 12 '23 Option Exercise 4.32 840 3,629 14,776 Jun 14 07:04 PM Tipirneni Praveen P. President and CEO Jun 12 '23 Sale 63.01 840 52,929 13,936 Jun 14 07:04 PM DeVaul William General Counsel and Secretary Jun 07 '23 Sale 60.05 7,756 465,742 13,338 Jun 09 07:00 PM Tipirneni Praveen P. President and CEO Jun 01 '23 Option Exercise 4.32 3,597 15,539 17,533 Jun 02 07:01 PM Tipirneni Praveen P. President and CEO Jun 01 '23 Sale 57.14 3,597 205,519 13,936 Jun 02 07:01 PM DeVaul William General Counsel and Secretary May 24 '23 Sale 60.00 100 6,000 21,094 May 25 08:44 PM Farrell Robert E Jr SVP Finance and CAO May 23 '23 Option Exercise 4.32 10,000 43,200 33,708 May 25 08:45 PM Farrell Robert E Jr SVP Finance and CAO May 23 '23 Sale 60.00 10,000 600,000 23,708 May 25 08:45 PM DeVaul William General Counsel and Secretary May 23 '23 Sale 60.03 3,802 228,236 21,194 May 25 08:44 PM Farrell Robert E Jr SVP Finance and CAO May 08 '23 Option Exercise 4.32 11,486 49,620 23,708 May 10 07:02 PM Rogers Bruce President May 05 '23 Option Exercise 4.32 16,000 69,042 133,055 May 09 07:03 PM Tipirneni Praveen P. President and CEO May 03 '23 Option Exercise 4.32 3,597 15,539 17,533 May 05 07:15 PM SPRINGER TIMOTHY A Director May 03 '23 Buy 45.00 1,050,000 47,250,000 2,768,464 May 04 07:06 PM Tipirneni Praveen P. President and CEO May 03 '23 Sale 51.11 3,597 183,857 13,936 May 05 07:15 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite